CVRx (NasdaqGS:CVRX) 2025 Conference November 18, 2025 03:00 AM ET Company ParticipantsKevin Hykes - President and CEOKevin HykesCVRx. I've been in this role for about 20 months now, and it's my pleasure to speak to you this morning. CVRx, these are forward-looking statements available on our website. CVRx has developed the world's first neuromodulation therapy for the treatment of a cardiovascular disease. We have a $2.2 billion annual TAM, a well-defined patient population who have limited treatment optio ...